Browse > Article
http://dx.doi.org/10.3857/roj.2016.34.1.76

Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literature  

Joseph, Deepa (Department of Radiation Oncology, Nizam's Institute of Medical Sciences)
Irukulla, Monica Malik (Department of Radiation Oncology, Nizam's Institute of Medical Sciences)
Ahmed, Syed Fayaz (Department of Radiation Oncology, Nizam's Institute of Medical Sciences)
Valiyaveettil, Deepthi (Department of Radiation Oncology, Nizam's Institute of Medical Sciences)
Akram, Syed (Department of Radiation Oncology, Nizam's Institute of Medical Sciences)
Publication Information
Radiation Oncology Journal / v.34, no.1, 2016 , pp. 76-80 More about this Journal
Abstract
Pseudolymphoma is a nonspecific disease characterized by lesions with lymphomatous-appearing but benign accumulation of inflammatory cells. They generally present as small ulcero-nodular lesions confined to skin which often respond to local therapies. We describe an unusual presentation of an extensive and locally aggressive cutaneous pseudolymphoma in a 21-year-old male patient who presented with extensive cutaneous eruptions gradually progressing over 6 years to involve the entire circumference of his left arm. Magnetic resonance imaging scans of his left arm showed a lesion deeply infiltrating into the soft tissue reaching up to the humerus with intense periosteal reaction. He was successfully treated with radiotherapy after many failed attempts with surgery and chemotherapy.
Keywords
Pseudolymphoma; Radiotherapy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998;38(6 Pt 1):877-95.   DOI
2 Taylor RB, Fortney JA, Pollack RB, Metcalf JS, Jenrette JM. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol 2010;28:385-7.   DOI
3 Safa G, Luce K, Darrieux L, Tisseau L, Ortonne N. Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy. J Am Acad Dermatol 2014;71:e149-50.   DOI
4 Kitagawa KH, Grassi M. Zoledronic acid-induced cutaneous B-cell pseudolymphoma. J Am Acad Dermatol 2011;65:1238-40.   DOI
5 Ingen-Housz-Oro S, Sbidian E, Ortonne N, et al. HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate. Dermatology 2013;226:15-8.   DOI
6 Robbins R, Peale AR, al-Saleem T. Pseudolymphomas. Am J Roentgenol Radium Ther Nucl Med 1970;108:149-53.   DOI
7 Gordon PS, Juillard GJ, Selch MT, Parker RG, Fu YS. Orbital lymphomas and pseudolymphomas: treatment with radiation therapy. Radiology 1986;159:797-9.   DOI
8 Fukuda H, Inoue Y, Nishimura Y, Takanashi R. Pseudolymphoma of the kidney: a case report. J Urol 1995;153:387-8.   DOI
9 Lin JJ, Farha GJ, Taylor RJ. Pseudolymphoma of the breast. I: in a study of 8,654 consecutive tylectomies and mastectomies. Cancer 1980;45:973-8.   DOI
10 Wood GS. Inflammatory diseases that simulate lymphomas: cutaneous pseudolymphomas. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York, NY: McGraw-Hill Companies, Inc; 2012.
11 Kerl H, Fink-Puches R, Cerroni L. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas. Keio J Med 2001;50:269-73.   DOI
12 Terada T. Cutaneous pseudolymphoma: a case report with an immunohistochemical study. Int J Clin Exp Pathol 2013;6:966-72.
13 Levy E, Godet J, Cribier B, Lipsker D. Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists. Ann Dermatol Venereol 2013;140:105-11.   DOI
14 Kluger N, Vermeulen C, Moguelet P, et al. Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients. J Eur Acad Dermatol Venereol 2010;24:208-13.   DOI
15 Gosain AK, Drolet BA, Neuburg M, Whittaker MH. Cutaneous pseudolymphoma: an unusual presentation of a deep subcutaneous thigh mass. Ann Plast Surg 1995;35:541-5.   DOI
16 Tomar S, Stoll HL, Grassi MA, Cheney R. Treatment of cutaneous pseudolymphoma with interferon alfa-2b. J Am Acad Dermatol 2009;60:172-4.   DOI
17 Benchikhi H, Bodemer C, Fraitag S, et al. Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases. J Am Acad Dermatol 1999;40(6 Pt 1):1005-7.   DOI
18 Ohzono A, Tsuruta D, Hashikawa K, et al. Three cases of pseudolymphoma successfully treated with amoxicillin. Eur J Dermatol 2013;23:717-8.
19 Olson LE, Wilson JF, Cox JD. Cutaneous lymphoid hyperplasia: results of radiation therapy. Radiology 1985;155:507-9.   DOI
20 Kulow BF, Cualing H, Steele P, et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg 2002;6:519-28.   DOI
21 Mikasa K, Watanabe D, Kondo C, Tamada Y, Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol 2005;53:911-2.   DOI